The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/37428
StudyName: Eligibility Triple Negative Breast Cancer NCT02032277
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 25.07.2019
License: Creative Commons BY 4.0

----

Description: 
A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02032277
